Ribrag, V <br/><br/>
Drug resistance mechanisms in chronic lymphocytic leukemia.  [electronic resource] 

 -  Leukemia  Dec 1996 
 - 1944-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--blood<br/>Antigens, Neoplasm<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chlorambucil--therapeutic use<br/>Cyclophosphamide--administration & dosage<br/>DNA Topoisomerases, Type II--blood<br/>DNA-Binding Proteins<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Drug Screening Assays, Antitumor<br/>Glutathione--blood<br/>Glutathione Transferase--blood<br/>HL-60 Cells--metabolism<br/>Humans<br/>Immunohistochemistry<br/>Isoenzymes--blood<br/>Leukemia, Lymphocytic, Chronic, B-Cell--blood<br/>Prednisone--administration & dosage<br/>Proliferating Cell Nuclear Antigen--blood<br/>Vincristine--administration & dosage